Eclampsia · women with pre‐eclampsia
Prevention of eclampsia: short showed no clear difference in eclampsia compared with standard maintenance regimen (subgroups by type of short regimen) (low certainty).
1 finding from 1 review
Severe morbidity · women with pre‐eclampsia
Prevention of eclampsia: short showed no clear difference in severe morbidity compared with standard maintenance regimen (subgroups by type of short regimen) (low certainty).
1 finding from 1 review
Side effect: respiratory depression · women with pre‐eclampsia
Prevention of eclampsia: short showed no clear difference in side effect: respiratory depression compared with standard maintenance regimen (subgroups by type of short regimen) (low certainty).
1 finding from 1 review
Death of baby (up to discharge) · women with pre‐eclampsia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maternal death · women with pre‐eclampsia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other neonatal morbidity · women with pre‐eclampsia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Days taken to achieve full feeding · preterm infants less than 1500 grams
1 finding from 1 review
Days to regain birth weight · preterm infants less than 1500 grams
1 finding from 1 review
Length of hospital stay · preterm infants less than 1500 grams
1 finding from 1 review
Necrotising enterocolitis · preterm infants less than 1500 grams
Short feeding interval showed no clear difference in necrotising enterocolitis compared with long feeding interval (low certainty).
1 finding from 1 review
Rate of weight gain (g/kg/day) · preterm infants less than 1500 grams
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality
Short‐acting insulin analogues showed no clear difference in all‐cause mortality (N) compared with regular human insulin (moderate certainty).
Severe hypoglycaemia
HbA1c (%)
Health‐related quality of life
Mortality: in‐hospital mortality (within 24 hours) · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: in‐hospital mortality (within 24 hours) compared with longer storage duration (low certainty).
1 finding from 1 review
Mortality: in‐hospital mortality (within 7 days) · all conditions
It is very uncertain whether transfusion of RBCs of shorter changes mortality: in‐hospital mortality (within 7 days) compared with longer storage duration (very low certainty).
1 finding from 1 review
Mortality: time‐point not defined · all conditions
It is very uncertain whether transfusion of RBCs of shorter changes mortality: time‐point not defined compared with longer storage duration (very low certainty).
1 finding from 1 review
Mortality: in‐hospital mortality (time points varied) · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: in‐hospital mortality (time points varied) compared with standard practice storage duration (moderate certainty).
1 finding from 1 review
ICU mortality · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: in‐ICU mortality compared with standard practice storage duration (moderate certainty).
1 finding from 1 review